Results 201 to 210 of about 75,915 (258)

Interaction of cytochrome P450 3A4 with the hydrophilic ligand tetraethylene glycol. [PDF]

Biochem Biophys Res Commun
Sevrioukova IF.
europepmc   +1 more source

Binding Site Vectors Enable Mapping of Cytochrome P450 Functional Landscapes. [PDF]

J Chem Inf Model
Kuvek T, Jandová Z, Schleifer KJ, Oostenbrink C.   +3 more
europepmc   +1 more source

Optimizing ribociclib dosing in breast cancer with brain metastasis patients using a physiologically based pharmacokinetic model. [PDF]

BMC Cancer
Zhang C, Li S, Ren J, Wen X.
europepmc   +1 more source

The Role of Clinical Pharmacogenetics and Opioid Interactions in Pain Management: Current Evidence and Future Perspectives. [PDF]

Pharmaceutics
Di Salvo C, Valdiserra G, Balestrieri S, Beucci G, Paciulli G, Luculli GI, De Vita A, Fornai M, Di Paolo A, Antonioli L.   +9 more
europepmc   +1 more source

Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers [PDF]

, 2018
et al,, Uy, Geoffrey L
core   +1 more source

Comparative analysis of sex-based, vendor-based, and species differences in cytochrome P450 metabolism. [PDF]

Sci Rep
Kinatukara N, Xu X, Shah P.
europepmc   +1 more source

Berberine and berberrubine promote the expression of CYP3A4 via enhancing the binding of nuclear receptor PXR. [PDF]

BMC Pharmacol Toxicol
Xiao GM, Lu T, Zhu D, Liu MY.
europepmc   +1 more source

Liver Necrosis in a Patient Receiving Isavuconazole: Making the Case for Therapeutic Drug Monitoring. [PDF]

Open Forum Infect Dis
Miceli MH, Eschenauer GA, Kauffman CA.
europepmc   +1 more source